Osama Mohamad, MD, PhD

Title(s)Assistant Professor, Radiation Oncology
SchoolSchool of Medicine
AddressLocation Required
Phone--
ORCID ORCID Icon0000-0002-2234-8273 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    American University of Beirut, BeirutB.S.06/2006Biology
    Emory University, AtlantaMD05/2014Medicine
    Emory University , AtlantaPhD06/2014Neuroscience and regenerative medicine
    University of Hawaii, Honolulu, HI06/2015Transitional year internship
    University of Texas Southwestern, Dallas06/2019Radiation Oncology Residency
    National Institute of Radiological Sciences, Chiba, Japan04/2018Research fellowship in carbon ion radiotherapy
    Collapse Awards and Honors
    University of Texas Southwestern Medical Center2018  - 2019Resident of the year chief resident award
    University of Texas Southwestern Medical Center2015  - 2019RSNA Roentgen research award
    Association of Residents in Radiation Oncology2017  - 2018ASTRO/ARRO Global Health Scholar Program Award
    University of Hawaii Transitional Year Program2014  - 2015Resident of the year awad
    Emory University2008  - 2009Crawford Long Anesthesiology Research Award
    Alpha Omega Alpha Honors Medical Society2006  - 2007Carolyn Kuckein Student Research Award
    American University of Beirut2004  - 2005Nicholas Jabr Award for Academic Excellence

    Collapse Overview 
    Collapse Overview
    Dr. Osama Mohamad received his undergraduate degree at the American University of Beirut, in Beirut, Lebanon in 2006 with the highest honors. He then enrolled in the medical scientist training program (MSTP) at Emory University in Atlanta, and successfully finished his MD Ph.D. (Ph.D. in stem cells and regenerative medicine) in 2014. During his Ph.D., he received a Howard Hughes Medical Institute Fellowship award and completed a certificate program in clinical and translational research. He completed a transitional year internship at the University of Hawaii (where he received the resident of the year award), then finished residency training in radiation oncology at the University of Texas Southwestern (UTSW) Medical Center, in Dallas (where he was a chief resident). During residency, he spent a year pursuing a research fellowship at the National Institute of Radiological Sciences in Japan studying carbon ion radiotherapy for prostate cancer. Over his years in training, he received many awards including the resident of the year award and the RSNA Roentgen research award during his chief resident year at UTSW. He presented his research at multiple national and international meetings and published over 45 publications.

    Dr. Mohamad’s number one priority is his patients. He is interested in healthcare innovation with a focus on oncology. He is passionate about clinical care and bringing cutting-edge research and innovation to his patients. At UCSF, he will be treating genitourinary cancers with a special focus on prostate and kidney cancers using intensity-modulated radiotherapy (IMRT), stereotactic radiotherapy (SBRT), and HDR brachytherapy. He will build on the strong interdisciplinary cancer clinical programs in the departments of urology, radiation oncology, and medical oncology at UCSF to develop clinical research, clinical trials, and translational research in prostate and kidney cancers.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol. 2023 Mar 01; JCO2202489. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV. PMID: 36857638.
      View in: PubMed   Mentions:    Fields:    
    2. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Mar 01. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, B?hmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.
      View in: PubMed   Mentions:    Fields:    
    3. Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med. 2023 Feb 22; 6(1):27. Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE, NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. PMID: 36813827; PMCID: PMC9947124.
      View in: PubMed   Mentions:
    4. Sediment prokaryotic microbial community and potential biogeochemical cycle from saline lakes shaped by habitat. Microbiol Res. 2023 Feb 21; 270:127342. Liu YH, Mohamad OAA, Gao L, Xie YG, Abdugheni R, Huang Y, Li L, Fang BZ, Li WJ. PMID: 36848700.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Outcomes of salvage high dose-rate brachytherapy with or without pelvic external beam radiotherapy in patients with palpable local recurrence of prostate cancer after radical prostatectomy. Brachytherapy. 2023 Jan 07. Ni L, Chen K, Phuong C, Sabbagh AR, Wong AC, Mohamad O, Hsu IC. PMID: 36623988.
      View in: PubMed   Mentions:    Fields:    
    6. Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey. JCO Glob Oncol. 2023 Jan; 9:e2200127. Mushonga M, Weiss J, Liu ZA, Nyakabau AM, Mohamad O, Tawk B, Moraes FY, Grover S, Yap ML, Zubizarreta E, Lievens Y, Rodin D. PMID: 36706350.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018. BMC Med. 2022 12 19; 20(1):488. Haeuser E, Serfes AL, Cork MA, Yang M, Abbastabar H, Abhilash ES, Adabi M, Adebayo OM, Adekanmbi V, Adeyinka DA, Afzal S, Ahinkorah BO, Ahmadi K, Ahmed MB, Akalu Y, Akinyemi RO, Akunna CJ, Alahdab F, Alanezi FM, Alanzi TM, Alene KA, Alhassan RK, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw EK, Amini S, Amugsi DA, Ancuceanu R, Anvari D, Appiah SCY, Arabloo J, Aremu O, Asemahagn MA, Jafarabadi MA, Awedew AF, Quintanilla BPA, Ayanore MA, Aynalem YA, Azari S, Azene ZN, Darshan BB, Babalola TK, Baig AA, Banach M, B?rnighausen TW, Bell AW, Bhagavathula AS, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew ZW, Bohlouli S, Bolarinwa OA, Boloor A, Bozicevic I, Butt ZA, C?rdenas R, Carvalho F, Charan J, Chattu VK, Chowdhury MAK, Chu DT, Cowden RG, Dahlawi SMA, Damiani G, Darteh EKM, Darwesh AM, das Neves J, Weaver ND, De Leo D, De Neve JW, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary SI, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu IJ, Ezzikouri S, Farzadfar F, Fattahi N, Fauk NK, Fernandes E, Filip I, Fischer F, Foigt NA, Foroutan M, Fukumoto T, Gad MM, Gaidhane AM, Gebregiorgis BG, Gebremedhin KB, Getacher L, Ghadiri K, Ghashghaee A, Golechha M, Gubari MIM, Gugnani HC, Guimar?es RA, Haider MR, Haj-Mirzaian A, Hamidi S, Hashi A, Hassanipour S, Hassankhani H, Hayat K, Herteliu C, Ho HC, Holla R, Hosseini M, Hosseinzadeh M, Hwang BF, Ibitoye SE, Ilesanmi OS, Ilic IM, Ilic MD, Islam RM, Iwu CCD, Jakovljevic M, Jha RP, Ji JS, Johnson KB, Joseph N, Joshua V, Joukar F, Jozwiak JJ, Kalankesh LR, Kalhor R, Kamyari N, Kanchan T, Matin BK, Karimi SE, Kayode GA, Karyani AK, Keramati M, Khan EA, Khan G, Khan MN, Khatab K, Khubchandani J, Kim YJ, Kisa A, Kisa S, Kopec JA, Kosen S, Laxminarayana SLK, Koyanagi A, Krishan K, Defo BK, Kugbey N, Kulkarni V, Kumar M, Kumar N, Kusuma D, La Vecchia C, Lal DK, Landires I, Larson HJ, Lasrado S, Lee PH, Li S, Liu X, Maleki A, Malik P, Mansournia MA, Martins-Melo FR, Mendoza W, Menezes RG, Mengesha EW, Meretoja TJ, Mestrovic T, Mirica A, Moazen B, Mohamad O, Mohammad Y, Mohammadian-Hafshejani A, Mohammadpourhodki R, Mohammed S, Mohammed S, Mokdad AH, Moradi M, Moraga P, Mubarik S, Mulu GBB, Mwanri L, Nagarajan AJ, Naimzada MD, Naveed M, Nazari J, Ndejjo R, Negoi I, Ngalesoni FN, Nguefack-Tsague G, Ngunjiri JW, Nguyen CT, Nguyen HLT, Nnaji CA, Noubiap JJ, Nu?ez-Samudio V, Nwatah VE, Oancea B, Odukoya OO, Olagunju AT, Olakunde BO, Olusanya BO, Olusanya JO, Bali AO, Onwujekwe OE, Orisakwe OE, Otstavnov N, Otstavnov SS, Owolabi MO, Mahesh PA, Padubidri JR, Pana A, Pandey A, Pandi-Perumal SR, Kan FP, Patton GC, Pawar S, Peprah EK, Postma MJ, Preotescu L, Syed ZQ, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi-Movaghar V, Rahmani AM, Ramezanzadeh K, Rana J, Ranabhat CL, Rao SJ, Rawaf DL, Rawaf S, Rawassizadeh R, Regassa LD, Rezaei N, Rezapour A, Riaz MA, Ribeiro AI, Ross JM, Rubagotti E, Rumisha SF, Rwegerera GM, Moghaddam SS, Sagar R, Sahiledengle B, Sahu M, Salem MR, Kafil HS, Samy AM, Sartorius B, Sathian B, Seidu AA, Shaheen AA, Shaikh MA, Shamsizadeh M, Shiferaw WS, Shin JI, Shrestha R, Singh JA, Skryabin VY, Skryabina AA, Soltani S, Sufiyan MB, Tabuchi T, Tadesse EG, Taveira N, Tesfay FH, Thapar R, Tovani-Palone MR, Tsegaye GW, Umeokonkwo CD, Unnikrishnan B, Villafa?e JH, Violante FS, Vo B, Vu GT, Wado YD, Waheed Y, Wamai RG, Wang Y, Ward P, Wickramasinghe ND, Wilson K, Yaya S, Yip P, Yonemoto N, Yu C, Zastrozhin MS, Zhang Y, Zhang ZJ, Hay SI, Dwyer-Lindgren L, Local Burden of Disease sub-Saharan Africa HIV Prevalence Collaborators. PMID: 36529768; PMCID: PMC9760541.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET. Cancers (Basel). 2022 Dec 15; 14(24). Sabbagh A, Mohamad O, Lichter KE, Hope TA. PMID: 36551678; PMCID: PMC9777467.
      View in: PubMed   Mentions:
    9. Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urol Oncol. 2022 Nov 24. Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ. PMID: 36435709.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Environmental Outcomes Associated With Transition From In-Person to a Virtual Oncology Conference During the COVID-19 Pandemic. JAMA Oncol. 2022 09 01; 8(9):1351-1352. Lichter KE, Drew T, Demeulenaere S, Wong E, Mohamad O, Yom SS, Bagshaw HP. PMID: 35737362; PMCID: PMC9227674.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    11. Transitioning to Environmentally Sustainable, Climate-Smart Radiation Oncology Care. Int J Radiat Oncol Biol Phys. 2022 08 01; 113(5):915-924. Lichter KE, Anderson J, Sim AJ, Baniel CC, Thiel CL, Chuter R, Collins A, Carollo E, Berg CD, Coleman CN, Abdel-Wahab M, Grover S, Singer L, Mohamad O. PMID: 35841919.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Environmentally sustainable brachytherapy care. Brachytherapy. 2022 Sep-Oct; 21(5):712-717. Lichter KE, Baniel CC, Anderson J, Bhatia R, Frick MA, Thiel CL, Gandhi S, Sarria GR, Bagshaw HP, Petereit D, Chino J, Grover S, Singer L, Hsu IC, Mohamad O. PMID: 35794032.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med. 2022 Jun 08; 5(1):71. Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE, NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. PMID: 35676445; PMCID: PMC9177850.
      View in: PubMed   Mentions: 2  
    14. The Time to Evaluate the Impact of PET PSMAs on Management of Prostate Cancer Is Now. Int J Radiat Oncol Biol Phys. 2022 06 01; 113(2):254-255. Mohamad O, Feng F. PMID: 35569471.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Relative Incidence of Emergency Department Visits After Treatment for Prostate Cancer With Radiation Therapy or Radical Prostatectomy. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e415-e422. Alexander J, Beatty A, Mohamad O, Hsu IJ. PMID: 35595216.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Synergistic Plant-Microbe Interactions between Endophytic Actinobacteria and Their Role in Plant Growth Promotion and Biological Control of Cotton under Salt Stress. Microorganisms. 2022 Apr 21; 10(5). Mohamad OAA, Liu YH, Li L, Ma JB, Huang Y, Gao L, Fang BZ, Wang S, El-Baz AF, Jiang HC, Li WJ. PMID: 35630312; PMCID: PMC9143301.
      View in: PubMed   Mentions:
    17. Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022 07 15; 113(4):825-832. Terbuch A, Posch F, Bauernhofer T, Jost PJ, Partl R, Stranzl-Lawatsch H, Baciarello G, Fizazi K, Giannatempo P, Verzoni E, Sweeney C, Ravi P, Tran B, Basso U, White J, Vincenzi B, Oing C, Cutuli HJ, Dieckmann KP, Gamulin M, Chovanec M, Fankhauser CD, Heidenreich A, Mohamad O, Thibault C, Fischer S, Gillessen S, International Germ Cell Cancer Collaborative Group. PMID: 35461737.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost. Radiat Oncol. 2022 Jan 20; 17(1):12. Phuong C, Chan JW, Ni L, Wall P, Mohamad O, Wong AC, Hsu IC, Chang AJ. PMID: 35057827; PMCID: PMC8772149.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. In Reply to Chowdhry. Int J Radiat Oncol Biol Phys. 2021 11 15; 111(4):1093. Chowdhary M, O'Bryant S, Vapiwala N, Mohamad O, Royce TJ. PMID: 34655557.
      View in: PubMed   Mentions:    Fields:    
    20. SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial. Int J Radiat Oncol Biol Phys. 2022 06 01; 113(2):290-301. Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, Timmerman RD. PMID: 34774676; PMCID: PMC9091061.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    21. PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. J Nucl Med. 2022 01; 63(1):76-80. Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJH, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert M. PMID: 34620731; PMCID: PMC8717195.
      View in: PubMed   Mentions: 5     Fields:    
    22. Biological data annotation via a human-augmenting AI-based labeling system. NPJ Digit Med. 2021 Oct 07; 4(1):145. van der Wal D, Jhun I, Laklouk I, Nirschl J, Richer L, Rojansky R, Theparee T, Wheeler J, Sander J, Feng F, Mohamad O, Savarese S, Socher R, Esteva A. PMID: 34620993; PMCID: PMC8497580.
      View in: PubMed   Mentions: 5  
    23. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2021 12 15; 27(24):6716-6725. Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J. PMID: 34551906.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    24. Treating Localized High-Risk Prostate Cancer: Do All Roads Lead to Rome? Int J Radiat Oncol Biol Phys. 2021 07 01; 110(3):634-635. Mohamad O, Feng F. PMID: 34089672.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. United States Radiation Oncology Fellowship Growth From 2010 to 2020. Int J Radiat Oncol Biol Phys. 2021 11 01; 111(3):622-626. Chowdhary M, O'Bryant S, Peters GW, Vapiwala N, Mohamad O, Royce TJ. PMID: 34147580.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death. J Clin Oncol. 2021 07 10; 39(20):2284-2293. Tilki D, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, B?hmer D, Mohamad O, Cowan JE, Feng FY, Carroll PR, Trock BJ, Partin AW, D'Amico AV. PMID: 34086480.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    27. Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Adv Radiat Oncol. 2021 Sep-Oct; 6(5):100692. Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R. PMID: 34646963; PMCID: PMC8498727.
      View in: PubMed   Mentions: 5  
    28. Radiation Delay Is Okay, but Where Is the Evidence? JAMA Oncol. 2021 03 01; 7(3):463-464. Mohamad O, Roach M. PMID: 33443566.
      View in: PubMed   Mentions:    Fields:    
    29. Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1135-1142. Margulis V, Freifeld Y, Pop LM, Manna S, Kapur P, Pedrosa I, Christie A, Mohamad O, Mannala S, Singla N, Wait M, Bagrodia A, Woldu SL, Gahan J, Brugarolas J, Timmerman R, Hannan R. PMID: 33549705; PMCID: PMC8856732.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    30. Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey. Radiother Oncol. 2021 04; 157:32-39. Rodin D, Tawk B, Mohamad O, Grover S, Moraes FY, Yap ML, Zubizarreta E, Lievens Y. PMID: 33453312; PMCID: PMC8053676.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    31. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021 03; 79(3):374-383. Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. PMID: 33293078.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    32. Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. Radiother Oncol. 2021 01; 154:207-213. Levin-Epstein RG, Jiang NY, Wang X, Upadhyaya SK, Collins SP, Suy S, Aghdam N, Mantz C, Katz AJ, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas N, Bagshaw H, Buyyounouski MK, Cao M, Agazaryan N, Dang A, Yuan Y, Kupelian PA, Zaorsky NG, Spratt DE, Mohamad O, Feng FY, Mahal BA, Boutros PC, Kishan AU, Juarez J, Shabsovich D, Jiang T, Kahlon S, Patel A, Patel J, Nickols NG, Steinberg ML, Fuller DB, Kishan AU. PMID: 33035622; PMCID: PMC7956167.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    33. Delaying Dilemmas: Coronavirus Complications Impacting the Management of Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 10 01; 108(2):337. Mohamad O, Roach M. PMID: 32890501; PMCID: PMC7462932.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    34. Margin-Free Fractionated Stereotactic Radiation Therapy for Pediatric Brain Tumors. Pract Radiat Oncol. 2020 Nov - Dec; 10(6):e485-e494. Mohamad O, Wardak Z, Bowers DC, Le AH, Dan T, Abdulrahman R, Gargan L, Klesse L, Weprin B, Swift D, Price A, Ding C, Stojadinovic S, Sklar F, Braga B, Timmerman R. PMID: 32428764.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Radiation Therapy for Pediatric Brain Tumors using Robotic Radiation Delivery System and Intensity Modulated Proton Therapy. Pract Radiat Oncol. 2020 May - Jun; 10(3):e173-e182. Lin MH, Yang M, Dougherty J, Tasson A, Zhang Y, Mohamad O, Dan T, Yan Y, Gu X, Timmerman R, Laack N, Beltran C. PMID: 31542454.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. Int J Radiat Oncol Biol Phys. 2019 10 01; 105(2):367-375. Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R. PMID: 31377159; PMCID: PMC7647381.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    37. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial. Support Care Cancer. 2020 Mar; 28(3):1481-1489. Rahimi A, Mohamad O, Albuquerque K, Kim DWN, Chen D, Thomas K, Wooldridge R, Rivers A, Leitch M, Rao R, Haley B, Ahn C, Garwood D, Spangler A. PMID: 31273506.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    38. Key considerations when reviewing subsequent primary cancers following radiotherapy - Authors' reply. Lancet Oncol. 2019 06; 20(6):e292. Mohamad O, Tabuchi T, Morishima T, Makishima H, Miyashiro I, Tsuji H. PMID: 31162099.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Oculomotor Schwannomas: A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy. World Neurosurg. 2019 Sep; 129:487-496. Fadel HA, El Ahmadieh TY, Plitt AR, Neeley OJ, Johnson Z, Aoun SG, Mohamad O, Timmerman R, Weprin BE. PMID: 31125775.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Fellowship Training Programs in Radiation Oncology: A Snapshot From 2005 to 2017. Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):765-772. Doke K, Mohamad O, Royce TJ, Meyer J, Chen AM. PMID: 30885774.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study. Lancet Oncol. 2019 05; 20(5):674-685. Mohamad O, Tabuchi T, Nitta Y, Nomoto A, Sato A, Kasuya G, Makishima H, Choy H, Yamada S, Morishima T, Tsuji H, Miyashiro I, Kamada T. PMID: 30885458.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    42. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study. Cancer Sci. 2019 Jan; 110(1):303-309. Makishima H, Yasuda S, Isozaki Y, Kasuya G, Okada N, Miyazaki M, Mohamad O, Matsufuji N, Yamada S, Tsuji H, Kamada T, Liver Cancer Working Group. PMID: 30417485; PMCID: PMC6317930.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    43. Predictors of Cardiac Sparing in Deep Inspiration Breath-Hold for Patients With Left Sided Breast Cancer. Front Oncol. 2018; 8:564. Mkanna A, Mohamad O, Ramia P, Thebian R, Makki M, Tamim H, Jalbout W, Youssef B, Eid T, Geara F, Shahine B, Zeidan YH. PMID: 30538954; PMCID: PMC6277631.
      View in: PubMed   Mentions: 8  
    44. Clinical Indications for Carbon Ion Radiotherapy. Clin Oncol (R Coll Radiol). 2018 05; 30(5):317-329. Mohamad O, Yamada S, Durante M. PMID: 29402598.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    45. Carbon ion radiotherapy for inoperable pediatric osteosarcoma. Oncotarget. 2018 May 01; 9(33):22976-22985. Mohamad O, Imai R, Kamada T, Nitta Y, Araki N, Working Group for Bone and Soft Tissue Sarcoma. PMID: 29796166; PMCID: PMC5955418.
      View in: PubMed   Mentions: 18     Fields:    
    46. A Fellow's Fate: Employment Outcomes of Radiation Oncology Fellowship Graduates. Int J Radiat Oncol Biol Phys. 2018 09 01; 102(1):16-17. Mohamad O, Doke K, Marcrom S, Chen AM, Royce TJ, Meyer JJ. PMID: 30102192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy. Oncoimmunology. 2018; 7(7):e1440168. Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, Hammers H, Choy H, Timmerman R, Brugarolas J, Hannan R. PMID: 29900043; PMCID: PMC5993514.
      View in: PubMed   Mentions: 18     Fields:    
    48. Evolution of Carbon Ion Radiotherapy at the National Institute of Radiological Sciences in Japan. Cancers (Basel). 2018 Mar 06; 10(3). Mohamad O, Makishima H, Kamada T. PMID: 29509684; PMCID: PMC5876641.
      View in: PubMed   Mentions: 16  
    49. Recent Trends in Radiation Oncology Fellowship Training in the United States. Int J Radiat Oncol Biol Phys. 2017 11 01; 99(3):539-540. Mohamad O, Meyer JJ. PMID: 29280447.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair. Cancers (Basel). 2017 Jun 09; 9(6). Mohamad O, Sishc BJ, Saha J, Pompos A, Rahimi A, Story MD, Davis AJ, Kim DWN. PMID: 28598362; PMCID: PMC5483885.
      View in: PubMed   Mentions: 51  
    51. Deep inspiration breathhold for left-sided breast cancer patients with unfavorable cardiac anatomy requiring internal mammary nodal irradiation. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):e361-e367. Mohamad O, Shiao J, Zhao B, Roach K, Ramirez E, Vo DT, Thomas K, Gu X, Spangler A, Albuquerque K, Rahimi A. PMID: 28666899.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    52. Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol. 2017 Oct; 157:49-78. Wei L, Wei ZZ, Jiang MQ, Mohamad O, Yu SP. PMID: 28322920; PMCID: PMC5603356.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimals
    53. Optogenetic stimulation of glutamatergic neuronal activity in the striatum enhances neurogenesis in the subventricular zone of normal and stroke mice. Neurobiol Dis. 2017 Feb; 98:9-24. Song M, Yu SP, Mohamad O, Cao W, Wei ZZ, Gu X, Jiang MQ, Wei L. PMID: 27884724; PMCID: PMC5315431.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    54. Congenital Mesenteric Defect: An Uncommon Cause of Bowel Obstruction. Hawaii J Med Public Health. 2016 Feb; 75(2):46-7. Benyamini P, Lopez S, Cooper M, Mohamad O, Maldini G. PMID: 26918208; PMCID: PMC4755067.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Absence of physiologic breast response to pregnancy and lactation after radiation therapy. Pract Radiat Oncol. 2016 Mar-Apr; 6(2):e25-6. Mohamad O, McFarlane M, Rahimi A. PMID: 26553113.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. BMC Cancer. 2014 Sep 26; 14:716. Chen D, Song M, Mohamad O, Yu SP. PMID: 25255962; PMCID: PMC4190379.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    57. Efficient neuronal differentiation of mouse ES and iPS cells using a rotary cell culture protocol. Differentiation. 2013 Nov-Dec; 86(4-5):149-58. Mohamad O, Yu SP, Chen D, Ogle M, Song M, Wei L. PMID: 24480155.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    58. Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice. Stem Cell Res Ther. 2013 Aug 08; 4(4):93. Drury-Stewart D, Song M, Mohamad O, Guo Y, Gu X, Chen D, Wei L. PMID: 23928330; PMCID: PMC3854684.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    59. Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice. Neuroscience. 2013 Nov 12; 252:489-500. Wei S, Sun J, Li J, Wang L, Hall CL, Dix TA, Mohamad O, Wei L, Yu SP. PMID: 23912033; PMCID: PMC3961766.
      View in: PubMed   Mentions: 29     Fields:    Translation:Animals
    60. Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice. PLoS One. 2013; 8(5):e64160. Mohamad O, Drury-Stewart D, Song M, Faulkner B, Chen D, Yu SP, Wei L. PMID: 23717557; PMCID: PMC3662762.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    61. Coordinated development of voltage-gated Na+ and K+ currents regulates functional maturation of forebrain neurons derived from human induced pluripotent stem cells. Stem Cells Dev. 2013 May 15; 22(10):1551-63. Song M, Mohamad O, Chen D, Yu SP. PMID: 23259973; PMCID: PMC3653388.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    62. Neurotrophic effects of leukemia inhibitory factor on neural cells derived from human embryonic stem cells. Stem Cells. 2012 Nov; 30(11):2387-99. Majumder A, Banerjee S, Harrill JA, Machacek DW, Mohamad O, Bacanamwo M, Mundy WR, Wei L, Dhara SK, Stice SL. PMID: 22899336.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    63. Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplant. 2013; 22(11):2001-15. Song M, Mohamad O, Gu X, Wei L, Yu SP. PMID: 23069268.
      View in: PubMed   Mentions: 42     Fields:    Translation:AnimalsCells
    64. Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice. J Physiol. 2013 Jan 01; 591(1):149-68. Mohamad O, Song M, Wei L, Yu SP. PMID: 23006484; PMCID: PMC3630778.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    65. A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice. FASEB J. 2012 Jul; 26(7):2799-810. Choi KE, Hall CL, Sun JM, Wei L, Mohamad O, Dix TA, Yu SP. PMID: 22459147; PMCID: PMC3382100.
      View in: PubMed   Mentions: 50     Fields:    Translation:Animals
    66. N-methyl-D-aspartate receptor subtype 3A promotes apoptosis in developing mouse brain exposed to hyperoxia. Neural Regen Res. 2012 Feb 05; 7(4):273-7. Li J, Yu S, Lu Z, Mohamad O, Wei L. PMID: 25806068; PMCID: PMC4353099.
      View in: PubMed   Mentions:
    67. Erythropoietin reduces neuronal cell death and hyperalgesia induced by peripheral inflammatory pain in neonatal rats. Mol Pain. 2011 Jul 21; 7:51. Mohamad O, Chen D, Zhang L, Hofmann C, Wei L, Yu SP. PMID: 21777449; PMCID: PMC3161880.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    68. Small molecule promoted feeder free and adherent differentiation of functional neurons from human embryonic and induced pluripotent stem cells. J Stem Cells. 2011; 6(1):1-7. Drury-Stewart D, Song M, Mohamad O, Yu SP, Wei L. PMID: 22997841.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    69. Sublethal transient global ischemia stimulates migration of neuroblasts and neurogenesis in mice. Transl Stroke Res. 2010 Sep; 1(3):184-96. Li Y, Yu SP, Mohamad O, Genetta T, Wei L. PMID: 21792374; PMCID: PMC3142584.
      View in: PubMed   Mentions: 15     Fields:    
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Osama's Networks
    Concepts (275)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (45)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04.

    Copyright © The Regents of the University of California